Aqueous formulations of peptides, preferably LHRH

摘要

This specification describes stable liquid aqueous formulations of peptide compounds at high concentrations. These stable formulations comprise at least about 10 % peptide in water. They may be stored at elevated temperatures for long periods of time and are especially useful in implantable delivery devices for long term delivery of drug. Preferred peptides include leuprolide, LHRH, nafarelin and goserelin.